跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-TRAMADOL ER - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-TRAMADOL ER
Authorized
STANDARD
TARO-TRAMADOL ER
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bafffd62eafe2f19
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
bafffd62eafe2f19
Drug Approval Canada Name
TARO-TRAMADOL ER
Product Name
TARO-TRAMADOL ER
Status
Marketed
Status Date
2016-05-27
Original Market Date
2016-05-27
Din
02450437
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N02AX02 TRAMADOL
Atc Name
n 02 ax 02
Aig Number
0151694003
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
TRAMADOL HYDROCHLORIDE
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bafffd62eafe2f19
Type
Standard
Back to Health Canada Approvals